US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AI Healthcare

635.02

+16.192.62%

Number of Gainers:3

Number of Losers:- -

Number of Flat:1

PE:- -

High:636.36

Open:617.98

Low:605.19

Close:618.83

Volume:21.40M

Turnover:419.91M

Market Cap:19.73B

Float Cap:14.41B

Loading ...

Is Recursion Pharmaceuticals (RXRX) Pricing Reflect Its Steep Share Price Declines And DCF Outlook

Simply Wall St.

Recursion Pharmaceuticals Director Christopher Gibson Reports Sale of Common Shares

Recursion’s REC-4881 Cancer Trial Terminated: Reading the Signals for RXRX Investors

Beam Therapeutics announces upcoming board member resignation

Beam Therapeutics Director Carole Ho Resigns

Tempus AI-Tochter Ambry Genetics unterstützt bahnbrechende Forschung zu Krebsgenen

What's Going On With Tempus AI Stock Monday?

Benzinga_recent_news

Ambry Genetics Hits One Million RNA-Enhanced Genetic Tests Under Tempus AI

IBM, P&G, GameStop, Crispr, AGNC: Insider Moves Exposed

Tempus AI CEO Eric Lefkofsky Reports Sale of Common Shares

Assessing Tempus AI (TEM) Valuation After New Immune Profile Score Breakthrough

Simply Wall St.

Cathie Wood’s ARK Investment buys 127K shares of Crispr Therapeutics today

Assessing CRISPR Therapeutics (CRSP) Valuation After Recent Share Price Movements

Simply Wall St.

Top Executive Makes Bold Move With Fresh Crispr Therapeutics AG Stock Buy

Tempus Says Study Shows AI-Driven Test More Accurately Predicts Immunotherapy Benefits

MT Newswires Live

Cathie Wood Sells Biotech Stocks, Bets Big on Tempus AI and WeRide

Cathie Wood Bets Big On AI Trifecta: Ark Deploys $1.4 Million Across Medical, Autonomous Driving Sectors

Benzinga_recent_news

Nancy Pelosi Discloses Buys Of Nvidia, Apple, AllianceBernstein, And More; Sells Some Stakes

CRISPR Therapeutics AG CFO Prasad Raju Reports Disposal of Common Shares

Beam Therapeutics Chief Legal Officer Christine Bellon Reports Sale of Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4611/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4611","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","market":"US","secType":"PLATE","nameCN":"AI Healthcare","latestPrice":635.017,"timestamp":1770670799999,"preClose":618.8305,"halted":0,"volume":21397475,"delay":0,"changeRate":0.026157,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":16.186523,"latestTime":"02-09 16:00:00 EST","open":617.98065,"high":636.36163,"low":605.1934,"amount":419914392.066162,"amplitude":0.050366,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770733800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.305529,"peRate":-10.482337,"turnoverRate":0.030692,"increases":3,"decrements":1,"flats":0,"marketCap":19730475520,"floatMarketCap":14408805888},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","high":636.36163,"amplitude":0.050366,"preClose":618.8305,"low":605.1934,"pbRate":"4.305529","latestPrice":635.017,"volume":21397475,"delay":0,"open":617.98065,"prevYearClose":658.3995,"prevWeekClose":618.8305,"prevMonthClose":653.7386,"prevQuarterClose":658.3995,"fiveDayClose":654.4818,"twentyDayClose":706.2519,"sixtyDayClose":714.6468,"secType":"PLATE","market":"US","turnoverRate":0.030692,"peRate":-10.482337,"marketCap":19730475520,"floatMarketCap":14408805888,"timestamp":1770670799999,"nameCN":"AI Healthcare"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4611\",,,,undefined,":{"bkCode":"BK4611","up":3,"down":0,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4611\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610073505","title":"Is Recursion Pharmaceuticals (RXRX) Pricing Reflect Its Steep Share Price Declines And DCF Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2610073505","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610073505?lang=en_us&edition=fundamental","pubTime":"2026-02-09 07:12","pubTimestamp":1770592335,"startTime":"0","endTime":"0","summary":"If you are wondering whether Recursion Pharmaceuticals' current share price lines up with its underlying worth, you are not alone. This article will walk through what the numbers suggest about value.\nThe stock last closed at US$3.98, after share price returns of a 5.0% decline over 7 days, 14.6% decline over 30 days, 5.2% decline year to date, and 46.9% decline over the past year, with a 51.4% decline over three years.\nRecently, headlines around Recursion Pharmaceuticals have focused on its...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rxrx/recursion-pharmaceuticals/news/is-recursion-pharmaceuticals-rxrx-pricing-reflect-its-steep","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rxrx/recursion-pharmaceuticals/news/is-recursion-pharmaceuticals-rxrx-pricing-reflect-its-steep","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK4548","BK4609","RXRX","BK4611","BK4539"],"gpt_icon":0},{"id":"2609016512","title":"Recursion Pharmaceuticals Director Christopher Gibson Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2609016512","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609016512?lang=en_us&edition=fundamental","pubTime":"2026-02-07 06:54","pubTimestamp":1770418454,"startTime":"0","endTime":"0","summary":"Christopher Gibson, Director at Recursion Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDLblzfDv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Recursion Pharmaceuticals Director Christopher Gibson Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RXRX","BK4548","BK4539","BK4609","BK4611"],"gpt_icon":0},{"id":"2609590049","title":"Recursion’s REC-4881 Cancer Trial Terminated: Reading the Signals for RXRX Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2609590049","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609590049?lang=en_us&edition=fundamental","pubTime":"2026-02-07 00:30","pubTimestamp":1770395453,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals, Inc ($RXRX) announced an update on their ongoing clinical study. Recursion Pharmaceuticals Ends Mid-Stage Cancer Study o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/recursions-rec-4881-cancer-trial-terminated-reading-the-signals-for-rxrx-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/recursions-rec-4881-cancer-trial-terminated-reading-the-signals-for-rxrx-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4609","BK4139","BK4211","BK4548","BK4611","BK4539","RXRX"],"gpt_icon":0},{"id":"2609587584","title":"Beam Therapeutics announces upcoming board member resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=2609587584","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609587584?lang=en_us&edition=fundamental","pubTime":"2026-02-06 05:39","pubTimestamp":1770327573,"startTime":"0","endTime":"0","summary":"Beam Therapeutics ( ($BEAM) ) has provided an announcement. On January 31, 2026, Beam Therapeutics Inc. announced that board member Dr. Carole Ho h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beam-therapeutics-announces-upcoming-board-member-resignation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beam-therapeutics-announces-upcoming-board-member-resignation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU1861559042.SGD","BK4505","BK4556","BK4535","LENZ","BK4139","BEAM","LU1861558580.USD","BK4585","BK4539","BK4611","BK4007"],"gpt_icon":0},{"id":"2609584513","title":"Beam Therapeutics Director Carole Ho Resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2609584513","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609584513?lang=en_us&edition=fundamental","pubTime":"2026-02-06 05:09","pubTimestamp":1770325775,"startTime":"0","endTime":"0","summary":"Beam Therapeutics Inc. announced that Carole Ho has resigned from its Board of Directors, effective February 27, 2026. The company stated that her resignation was not due to any disagreement with its operations, policies, or practices.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beam Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDLjF1lz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","BK4611","BK4556","BK4585","LU1861559042.SGD","BEAM","LU1861558580.USD","BK4535","BK4588"],"gpt_icon":0},{"id":"2608366509","title":"Tempus AI-Tochter Ambry Genetics unterstützt bahnbrechende Forschung zu Krebsgenen","url":"https://stock-news.laohu8.com/highlight/detail?id=2608366509","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608366509?lang=en_us&edition=fundamental","pubTime":"2026-02-04 20:01","pubTimestamp":1770206474,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Business Wire  on February 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL8Rtft7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","BK4611","BK4613","BK4121","TEM","LU1861559042.SGD"],"gpt_icon":1},{"id":"2608861213","title":"What's Going On With Tempus AI Stock Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2608861213","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608861213?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:03","pubTimestamp":1770037380,"startTime":"0","endTime":"0","summary":"Ambry Genetics, a subsidiary of Tempus AI, announced completion of 1 million DNA/RNA tests for hereditary cancer and rare disease.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/02/Tempus-Logo-Displayed-On-Smartphone.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/02/Tempus-Logo-Displayed-On-Smartphone.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/26/02/50296224/whats-going-on-with-tempus-ai-stock-monday-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/02/50296224/whats-going-on-with-tempus-ai-stock-monday-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4217","BK4121","BK4613","BK4588","BK4505","BK4551","LU1861559042.SGD","BK4611","BK4585","IE0009354923.USD","BK4139","BK4109","BK4023","BK4543","TEM","LU1861558580.USD","BK4528","BK4587"],"gpt_icon":1},{"id":"2608865069","title":"Ambry Genetics Hits One Million RNA-Enhanced Genetic Tests Under Tempus AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2608865069","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608865069?lang=en_us&edition=fundamental","pubTime":"2026-02-02 20:00","pubTimestamp":1770033651,"startTime":"0","endTime":"0","summary":"Ambry Genetics, a leader in clinical genomic testing, is a wholly owned subsidiary of Tempus AI, Inc. . Ambry Genetics has pioneered paired DNA/RNA testing for hereditary cancer and recently completed its one-millionth DNA/RNA test. The company first implemented RNA testing in 2016 and launched its commercial +RNAinsight test in 2019. In 2024, Ambry Genetics added RNA testing to its ExomeReveal offering to improve diagnostic yield in rare disease cases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Business Wire  on February 02, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDL8n7tPK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","BK4613","TEM","LU1861559042.SGD","LU1861558580.USD","BK4121"],"gpt_icon":0},{"id":"2607071202","title":"IBM, P&G, GameStop, Crispr, AGNC: Insider Moves Exposed","url":"https://stock-news.laohu8.com/highlight/detail?id=2607071202","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607071202?lang=en_us&edition=fundamental","pubTime":"2026-01-31 21:00","pubTimestamp":1769864441,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($IBM)), (($PG)), (($GME)), (($CRSP)) and (($AGNC)). Here is a breakdown of their recent trades and the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/ibm-pg-gamestop-crispr-agnc-insider-moves-exposed?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/ibm-pg-gamestop-crispr-agnc-insider-moves-exposed?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE000M9KFDE8.USD","AGNC","BK4543","LU1868837300.USD","SG9999014542.SGD","BK4139","BK4559","BK4538","LU0098860793.USD","LU1868836591.USD","LU0094547139.USD","BK4575","LU2129689514.USD","LU0237698245.USD","GME","IE00BLSP4239.USD","LU1868836914.USD","LU1868836757.USD","LU2242652126.USD","SG9999015341.SGD","SG9999002224.SGD","LU0689626769.HKD","LU1066053197.SGD","LU0320765646.SGD","LU1861558580.USD","LU2129689431.USD","BK4110","BK4547","BK4602","LU1674673691.USD","SG9999014559.SGD","IE00B3T34201.USD","SG9999001440.SGD","BK4533","IBM","LU0942090050.USD","LU1162221912.USD","LU1868837136.USD","GB00BDT5M118.USD","CRSP","LU0096364046.USD","LU0640476718.USD","LU1585245621.USD","LU2129689605.HKD","IE00BN8TJ469.HKD","LU1894683348.USD","BK4585","LU1280957306.USD","LU0868494708.USD","LU2097829019.USD","LU2552382058.USD","BK4577","LU1894683264.USD","SG9999014567.USD","BK4556","BK4558","LU0234572021.USD","LU0868494617.USD","SG9999014575.USD","BK4612","LU1430594728.SGD","SG9999002232.USD","BK4534","BK4550","LU0234570918.USD","PG","LU1880398554.USD","SG9999015358.SGD","BK4504","IE00B1XK9C88.USD","LU0321505439.SGD","BK4581","BK4611","LU2552382132.HKD","LU0124676726.USD","BK4018","LU2242646821.SGD","LU0323591593.USD","LU1861559042.SGD","LU2552382215.SGD","LU1929549753.HKD","LU0321505868.SGD","BK4579","LU1674673428.USD","LU1778281490.HKD","IE00BWXC8680.SGD","BK4567","LU0061475181.USD","BK4134","LU1883839398.USD","LU1880398471.USD","LU1914381329.SGD","BK4588","BK4076","IE00BLSP4452.SGD","IE00BBT3K403.USD","LU1066051498.USD"],"gpt_icon":0},{"id":"2607202194","title":"Tempus AI CEO Eric Lefkofsky Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2607202194","media":"Reuters","labels":["insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607202194?lang=en_us&edition=fundamental","pubTime":"2026-01-31 05:16","pubTimestamp":1769807762,"startTime":"0","endTime":"0","summary":"Eric P. Lefkofsky, CEO and Chairman of Tempus AI Inc., reported a disposal of Class A common shares of Tempus AI Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 30, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDLVCjLB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Tempus AI CEO Eric Lefkofsky Reports Sale of Common Shares","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM","LU1861559042.SGD","BK4611","BK4613","BK4121","LU1861558580.USD"],"gpt_icon":1},{"id":"2607040225","title":"Assessing Tempus AI (TEM) Valuation After New Immune Profile Score Breakthrough","url":"https://stock-news.laohu8.com/highlight/detail?id=2607040225","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607040225?lang=en_us&edition=fundamental","pubTime":"2026-01-30 19:37","pubTimestamp":1769773030,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) has drawn fresh attention after releasing clinical validation data on its Immune Profile Score test, which the company reports more accurately predicts which cancer patients benefit from immune checkpoint inhibitors than conventional biomarkers.\nSee our latest analysis for Tempus AI.\nThose IPS results arrive after a busy month for Tempus AI, with the launch of Paige Predict in digital pathology and fresh attention from high profile investors such as ARK and Nancy Pelosi. Even...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/assessing-tempus-ai-tem-valuation-after-new-immune-profile-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/assessing-tempus-ai-tem-valuation-after-new-immune-profile-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4023","LU1861558580.USD","BK4587","BK4585","BK4121","LU1861559042.SGD","BK4588","BK4528","TEM","BK4611","BK7095","BK4613","BK4551","BK4543"],"gpt_icon":1},{"id":"2607179065","title":"Cathie Wood’s ARK Investment buys 127K shares of Crispr Therapeutics today","url":"https://stock-news.laohu8.com/highlight/detail?id=2607179065","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607179065?lang=en_us&edition=fundamental","pubTime":"2026-01-30 09:05","pubTimestamp":1769735111,"startTime":"0","endTime":"0","summary":"20:04 EST Cathie Wood’s ARK Investment buys 127K shares of Crispr Therapeutics (CRSP) today Published first on TheFly – the ultimate source for rea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-127k-shares-of-crispr-therapeutics-today-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-127k-shares-of-crispr-therapeutics-today-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4611","LENZ","BK4007","BK4544","BK4539","LU1861559042.SGD","CRSP","LU1861558580.USD","BK4588","BK4139","BK4585","ARKK","BK4556"],"gpt_icon":0},{"id":"2607706474","title":"Assessing CRISPR Therapeutics (CRSP) Valuation After Recent Share Price Movements","url":"https://stock-news.laohu8.com/highlight/detail?id=2607706474","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607706474?lang=en_us&edition=fundamental","pubTime":"2026-01-29 11:43","pubTimestamp":1769658221,"startTime":"0","endTime":"0","summary":"Recent performance context for CRISPR Therapeutics (CRSP)\nCRISPR Therapeutics (CRSP) has drawn attention after a mixed stretch in its share performance, including a modest move over the past month and a decline in the past 3 months from recent levels.\nSee our latest analysis for CRISPR Therapeutics.\nAt a latest share price of US$53.69, CRISPR Therapeutics has seen weaker momentum recently, with a 90 day share price return of 12.13% and a 1 year total shareholder return of 30.28%, while the 5...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/assessing-crispr-therapeutics-crsp-valuation-after-recent-sh-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/assessing-crispr-therapeutics-crsp-valuation-after-recent-sh-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","LU1861558580.USD","BK4588","BK4611","BK4139","LU1861559042.SGD","DCF","BK4556","CRSP"],"gpt_icon":0},{"id":"2606750245","title":"Top Executive Makes Bold Move With Fresh Crispr Therapeutics AG Stock Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2606750245","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606750245?lang=en_us&edition=fundamental","pubTime":"2026-01-28 10:01","pubTimestamp":1769565703,"startTime":"0","endTime":"0","summary":"New insider activity at Crispr Therapeutics AG ( ($CRSP) ) has taken place on January 27, 2026. CMO Naimish Patel of Crispr Therapeutics AG recentl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-bold-move-with-fresh-crispr-therapeutics-ag-stock-buy-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-bold-move-with-fresh-crispr-therapeutics-ag-stock-buy-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4210","BK4139","BK4588","BK4611","BK4585","LU1861559042.SGD","BK4539","BK4556","BK4007","LU1861558580.USD","CRSP"],"gpt_icon":0},{"id":"2606780253","title":"Tempus Says Study Shows AI-Driven Test More Accurately Predicts Immunotherapy Benefits","url":"https://stock-news.laohu8.com/highlight/detail?id=2606780253","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606780253?lang=en_us&edition=fundamental","pubTime":"2026-01-27 22:24","pubTimestamp":1769523886,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) said Tuesday that results of a new study show that its Immune Profile Score algorithmic test predicts outcomes for patients receiving immune checkpoint inhibitors more accurately than ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1861558580.USD","BK7095","TEM","BK4613","BK4611","BK4121","LU1861559042.SGD"],"gpt_icon":0},{"id":"2606271269","title":"Cathie Wood Sells Biotech Stocks, Bets Big on Tempus AI and WeRide","url":"https://stock-news.laohu8.com/highlight/detail?id=2606271269","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606271269?lang=en_us&edition=fundamental","pubTime":"2026-01-27 11:30","pubTimestamp":1769484613,"startTime":"0","endTime":"0","summary":"Cathie Wood’s ARK Invest ETFs released their daily trade disclosures for Monday, January 26, 2026, highlighting fresh moves across biotech and arti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/cathie-wood-sells-biotech-stocks-bets-big-on-tempus-ai-and-weride?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/cathie-wood-sells-biotech-stocks-bets-big-on-tempus-ai-and-weride?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKK","BK4613","BK4121","BK4611","BK4585","TEM","LU1861559042.SGD","BK4544","LU1861558580.USD","BK4588"],"gpt_icon":0},{"id":"2606560275","title":"Cathie Wood Bets Big On AI Trifecta: Ark Deploys $1.4 Million Across Medical, Autonomous Driving Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=2606560275","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606560275?lang=en_us&edition=fundamental","pubTime":"2026-01-27 09:56","pubTimestamp":1769478960,"startTime":"0","endTime":"0","summary":"On Monday, Jan. 26, 2026, Cathie Wood's Ark Invest deployed approximately $1.4 million across three AI companies—Tempus AI, Kodiak AI, and WeRide","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/26/Ark-Invest-Cathie-Wood.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/26/Ark-Invest-Cathie-Wood.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/etfs/broad-u-s-equity-etfs/26/01/50146208/cathie-wood-bets-big-on-ai-trifecta-ark-deploys-1-4-million-across-medical-autonomous-driving-sectors","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/etfs/broad-u-s-equity-etfs/26/01/50146208/cathie-wood-bets-big-on-ai-trifecta-ark-deploys-1-4-million-across-medical-autonomous-driving-sectors","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["TEM","00800","BK4585","BK4611","BK4587","BK4613","BK4544","WRD","LU1861558580.USD","BK4121","BK4588","BK4124","KDK","BK4023","BK4528","BK4609","BK4551","LU1861559042.SGD","BK4543"],"gpt_icon":1},{"id":"2606223947","title":"Nancy Pelosi Discloses Buys Of Nvidia, Apple, AllianceBernstein, And More; Sells Some Stakes","url":"https://stock-news.laohu8.com/highlight/detail?id=2606223947","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606223947?lang=en_us&edition=fundamental","pubTime":"2026-01-27 08:16","pubTimestamp":1769472999,"startTime":"0","endTime":"0","summary":"Nancy Pelosi discloses millions of dollars in stock purchases, stock sales, options transactions and donated shares. Here's a look at the trades.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"fc98ea1bdd1ed5baf64683be3f4a9cfa","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/politics/26/01/50139122/nancy-pelosi-discloses-new-stock-trades-heres-what-shes-loading-up-on-and-whats-shes-selling","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Nancy Pelosi Discloses Buys Of Nvidia, Apple, AllianceBernstein, And More; Sells Some Stakes","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051811.HKD","LU0175139822.USD","LU1267930730.SGD","LU1868836757.USD","IE00BK4W5L77.USD","IE00BKVL7J92.USD","LU2361045086.USD","SG9999004303.SGD","LU1721428933.USD","LU0157215616.USD","LU0069063385.USD","LU2106854487.HKD","IE00B19Z3B42.SGD","LU1917777945.USD","BK4567","LU2360032135.SGD","IE00BJJMRY28.SGD","LU0444971666.USD","LU2065169927.USD","LU0210536198.USD","LU0348723411.USD","LU2357125470.USD","IE000M9KFDE8.USD","LU1989771016.USD","LU0820561818.USD","SG9999015952.SGD","LU2028103732.USD","LU1989764664.SGD","LU1046421795.USD","LU2125154935.USD","LU0476273544.USD","IE00BYQQ9H92.USD","LU2023250843.SGD","BK4532","IE00BJTD4V19.USD","IE00BDGV0183.EUR","LU0820561909.HKD","LU0068578508.USD","LU0347712357.USD","LU2191332357.HKD","LU2092937148.SGD","LU1670710588.SGD","LU0266013472.USD","IE00BVYPNP33.GBP","LU2317271919.USD","LU2087625088.SGD","LU2462157665.USD","LU1861220033.SGD","BK4571","BK4579","LU2471134523.USD","LU2458330243.SGD","LU2108987350.USD","LU0061474705.USD","LU1983260115.SGD","LU2491050154.USD","LU2089283258.USD","IE00BJJMRX11.SGD","LU2543165471.USD","LU0345774631.USD","LU0390134368.USD","LU0256863902.USD","SG9999002232.USD","LU0648000940.SGD","LU0342679015.USD","LU2125909247.SGD","SG9999011175.SGD","SG9999014559.SGD","IE00BQXX3F31.USD","LU1988902786.USD","LU2506951792.HKD","LU1035773651.USD","LU0795875169.SGD","IE0034235188.USD","LU0912757837.SGD","LU1951198990.SGD","LU2456880835.USD","LU1720051017.SGD","BK7095","LU0528227936.USD","IE00BN8TJ469.HKD","LU1778281490.HKD","LU2041044095.USD","LU2491050071.SGD","LU2264538146.SGD","LU1852331112.SGD","IE00B19Z3581.USD","BK4149","IE00BFSS7M15.SGD","IE00BLSP4239.USD","LU1506573853.SGD","SGXZ31699556.SGD","LU2552382058.USD","LU0345768153.USD","IE00B1XK9C88.USD","LU2133065610.SGD","LU1267930490.SGD","LU0861579265.USD","BK4581","LU0882574139.USD","BK4515","LU1548497426.USD","IE00BKDWB100.SGD","LU1366333091.USD","LU1935043536.SGD","LU2083900584.USD","LU2125154778.USD","LU1003077747.HKD","LU2272731865.HKD","LU1261432733.SGD","BK4585","IE00BMPRXQ63.HKD","BK4592","LU0672654240.SGD","LU2347655156.SGD","BK4550","LU1670711040.USD","SG9999015341.SGD","LU2168564222.USD","LU0965509101.SGD","LU0154236417.USD","LU0868494617.USD","LU2237443622.USD","LU1242518857.USD","LU0980610538.SGD","LU2087621335.USD","IE00BN29S564.USD","LU0320765646.SGD","LU2089985449.USD","BK4553","LU0823434583.USD","LU2272731600.USD","LU2279689827.SGD","LU0072461881.USD","LU0823414551.USD","AB","IE00BZ18W456.USD","SG9999018857.SGD","LU1037948541.HKD","LU0265550359.USD","LU0353189680.USD","IE00BVYPNW00.USD","LU1571399168.USD","LU2063271972.USD","LU0006306889.USD","LU1066053197.SGD","IE0002270589.USD","IE00BHPRN162.USD","BK4604","LU2237957902.USD","LU0353189763.USD","LU0823421333.USD","LU0289961442.SGD","LU2077746001.SGD","LU1861127337.USD","BK4141","BK4575","LU1861558580.USD","LU0211328371.USD","LU2054465674.USD","LU1868836914.USD","HK0000320223.HKD","LU2244417387.USD","LU1791710582.SGD","BK4608","LU0314104364.USD","LU0784385840.USD","LU2458330169.SGD","LU0072462426.USD","SG9999002224.SGD","IE00B5TLWC47.USD","LU0787776722.HKD","LU2420271590.USD","BK4559","LU1435385759.SGD","LU1923623000.USD","LU2471134796.USD","IE00B4YYXB79.USD","LU2430703251.USD","BK4612","LU0456855351.SGD","LU1791710400.SGD","BK4535","LU1839511570.USD","LU0203201768.USD","LU2764262908.HKD","LU0689626769.HKD","LU2023250504.SGD","LU2211815571.USD","SG9999001077.SGD","LU2750360997.AUD","LU2860962120.EUR","SG9999015978.USD","IE000KEQY171.SGD","LU1861559042.SGD","LU2764263039.SGD","LU0215105999.USD","IE00B5949003.HKD","LU2347655073.USD","BK4613","LU2552382215.SGD","BK4538","LU2430703178.SGD","LU0130103400.USD","SG9999001440.SGD","IE00B19Z9505.USD","AAPL","SG9999003800.SGD","LU1551013425.SGD","LU2211814178.USD","LU0234570918.USD","LU0238689110.USD","LU2362541513.USD","LU1496350171.SGD","LU2250418816.HKD","LU0081259029.USD","LU0979878070.USD","IE00BJLML261.HKD","LU0256863811.USD","LU1582987597.SGD","LU1629891620.HKD","BK4533","LU0274383776.USD","LU0225283273.USD","LU0276348264.USD","LU2361044949.HKD","LU2471134879.HKD","LU0265550946.USD","BK4121","SG9999014906.USD","LU0210528500.USD","LU2065171402.SGD","LU0162691827.USD","BK4220","LU0029864427.USD","LU1880398471.USD","LU2237443382.USD","LU2592432038.USD","LU0302445910.USD","LU2237443895.HKD","LU2756315664.SGD","LU2213496289.HKD","LU2362540622.SGD","LU1633808545.USD","LU0689472784.USD","LU0077335932.USD","LU0289739343.SGD","IE00BMCWC346.EUR","LU2896262040.SGD","IE0004445239.USD","LU2211817866.USD","LU0109392836.USD","LU0056508442.USD","LU0079474960.USD","IE00BKPKM429.USD","LU0345769631.USD","SG9999001424.SGD","LU0061475181.USD","LU2471134952.CNY","LU1153585028.USD","IE00B775SV38.USD","LU1804176565.USD","LU0203345920.USD","LU2357305700.SGD","LU2275660780.HKD","LU2242650005.HKD","LU1868837136.USD","LU1582987324.SGD","LU1301847155.USD","LU0053666078.USD","LU2403377893.USD","LU1691799644.USD","LU0310800379.SGD","LU0345770308.USD","LU0788109477.HKD","LU1989772840.SGD","LU2764263203.CNY","LU2125909593.SGD","LU0472753341.HKD","LU0267386448.USD","LU1119994496.HKD","IE0003U64NQ7.SGD","BK4554","LU1992135472.HKD","LU1720051108.HKD","LU0308772762.SGD","LU0433182093.SGD","LU1582986433.USD","BK4170","LU1674673428.USD","LU0784385170.HKD","LU0289960550.SGD","LU1868836591.USD","BK4534","IE00B4JS1V06.HKD","LU2097829019.USD","LU2092627202.USD","LU2237438978.USD","LU0511384066.AUD","IE00B42XCP33.USD","BK4596","LU1035775433.USD","LU1551013342.USD","IE0001KFT4U8.USD","BK4587","IE0004091025.USD","LU0726765562.USD","LU2023251221.USD","LU1815333072.USD","IE00B1BXHZ80.USD","BK4507","BK4524","HK0000320264.USD","LU1244550221.USD","LU2249611893.SGD","LU1670710661.SGD","LU1989772923.USD","LU0683600562.USD","LU1244550494.USD","BK4573","HK0000914686.HKD","LU2505996681.GBP","LU2237443465.HKD","LU1489326972.SGD","LU2023250330.USD","LU0444973449.USD","LU2720916845.USD","SG9999014575.USD","LU1974910355.USD","SG9999014542.SGD","LU2750360641.GBP","LU1127390331.HKD","HK0000914660.USD","BK4527","LU1935043023.USD","LU0130102774.USD","IE00B3SWFQ91.USD","LU0878866978.SGD","LU0557290698.USD","IE00B3S45H60.SGD","BK4598","LU2168564149.EUR","SG9999000418.SGD","LU0061474960.USD","LU1803068979.SGD","LU0048584097.USD","LU0314106906.USD","LU2236285917.USD","LU0320765489.SGD","IE00B19Z8W00.USD","SGXZ81514606.USD","LU0097036916.USD","SG9999014914.USD","IE00BGHQDM52.EUR","LU0345768740.USD","LU1914381329.SGD","LU0345770993.USD","IE00BDRTCR15.USD","LU2242649171.HKD","LU1868837300.USD","LU0965508806.USD","LU0957791311.USD","LU0094547139.USD","LU0170899867.USD","LU1037948897.HKD","IE00BGHQF631.EUR","LU2298321311.HKD","LU0210533765.USD","LU2361044865.SGD","LU2746668461.USD","IE0034235295.USD","LU0738911758.USD","LU2065171311.SGD","LU0795875086.SGD","LU1291159041.SGD","LU2247934214.USD","BK4122","LU0158827781.USD","LU1206712785.SGD","LU0128525929.USD","LU2360106780.USD","LU2111349929.HKD","LU1935042215.USD","LU2237443978.SGD","LU2463028550.USD","LU0985320562.USD","LU2125909916.SGD","IE00BZ18W340.USD","LU2097344357.USD","LU2602419157.SGD","LU2505996509.AUD","LU2413666699.HKD","LU0648001328.SGD","LU2286300806.USD","IE00B19Z8X17.USD","LU2756315318.SGD","LU2322448957.HKD","BK4576","LU0417517546.SGD","LU1084165304.USD","LU2931357623.SGD","LU1162221912.USD","IE000YTNTUN2.SGD","LU1242518931.SGD","LU0965509010.AUD","LU1674673691.USD","BK4574","LU0011850046.USD","LU0965509283.SGD","IE000W1ABFV2.USD","LU1366192091.USD","LU1670711123.USD","LU1699723380.USD","LU1116320737.USD","LU1732799900.SGD","LU0820562030.AUD","LU1883839398.USD","BK4551","LU0289941410.SGD","LU0203347892.USD","LU1934455863.HKD","LU0784383803.USD","LU1989764748.USD","IE00B19Z9Z06.USD","LU0198837287.USD","LU0943347566.SGD","IE00BVYPNV92.GBP","IE00BZ199S13.USD","LU1323610961.USD","LU0466842654.USD","LU2360108059.USD","GB00BDT5M118.USD","LU1821325948.USD","IE00BFSS8Q28.SGD","LU0323591593.USD","IE00BSNM7G36.USD","LU0312595415.SGD","HK0000306685.HKD","LU0082616367.USD","BK4549","LU1267930573.SGD","BK4105","SGXZ23171101.USD","LU2092937221.SGD","LU1093756325.SGD","LU2552382132.HKD","LU0107464264.USD","LU0234572021.USD","LU1116320901.HKD","LU2491049909.HKD","LU1429558221.USD","LU1066051225.USD","LU0345774391.USD","SG9999018865.SGD","LU1623119135.USD","LU0106261372.USD","LU0661504455.SGD","IE00BYXW3230.USD","LU0708995401.HKD","LU0251132253.USD","LU1935042488.USD","IE00BMPRXN33.USD","LU1316542783.SGD","BK4505","LU1201861249.SGD","LU1670628061.USD","LU1934455277.USD","LU0985489474.SGD","IE0004086264.USD","LU0320765059.SGD","LU0964807845.USD","LU2168563687.JPY","LU1712237335.SGD","IE00B7SZLL34.SGD","LU1069347547.HKD","IE00B19Z9P08.USD","IE00BD6J9T35.USD","LU0354030438.USD","LU0096362180.USD","LU1064131342.USD","LU2362541273.HKD","LU1201861165.SGD","LU0310799852.SGD","LU1732800096.USD","SG9999017495.SGD","BK4501","LU0124676726.USD","LU0545039389.USD","LU0057025933.USD","LU0823434740.USD","LU2237443549.SGD","LU2272731782.SGD","LU0949170772.SGD","IE0009356076.USD","LU2265009873.SGD","BK4503","BK4514","LU2355687059.USD","LU2746668974.SGD","LU1582986359.USD","SG9999015986.USD","LU2381873111.SGD","LU0823411888.USD","IE00BLSP4452.SGD","IE000ITXATA3.USD","LU2322448791.USD","LU0080751232.USD","LU0724617625.USD","SG9999014898.SGD","LU0070217475.USD","LU0642271901.SGD","LU2097344431.USD","LU1934455194.USD","SG9999014567.USD","BK4548","LU2360107168.USD","SG9999015358.SGD","IE00BFXG0V08.USD","LU1145028129.USD","LU2430703095.HKD","LU0786609619.USD","LU1235294995.USD","BK4602","LU1951200564.SGD","BK4077","BK4525","LU1814569148.SGD","SGXZ51526630.SGD","LU0640476718.USD","IE00B894F039.SGD","LU0823414478.USD","IE0034235303.USD","LU1923622614.USD","LU2125909759.SGD","LU0070302665.USD","IE00BWXC8680.SGD","LU1823568750.SGD","IE00BMPRXR70.SGD","LU1066051498.USD","LU0211327993.USD","IE00BQXX3C00.GBP","LU0784384876.USD","LU0149725797.USD","LU2168564495.EUR","LU2326559502.SGD","LU2413666426.HKD","LU0316494557.USD","LU0708994859.HKD","LU1496350502.SGD","LU0096364046.USD","LU0203202063.USD","BK4543","LU1718418525.SGD","LU2473716301.USD","LU2487616109.SGD","SG9999014880.SGD","BK4512","LU0354030511.USD","IE00BZ1G4Q59.USD","IE00BK4W5M84.HKD","BK4611","IE00BMQBXF63.USD","LU2271345857.HKD","BK4529","LU1244550577.SGD","LU2433249047.HKD","LU1232071149.USD","LU2290526834.HKD","IE00BFMHRM44.USD","LU2237957811.SGD","LU2452424414.USD","IE00B775H168.HKD","LU2417539215.USD","IE00BJTD4N35.SGD","HK0000306701.USD","LU1861215975.USD","LU1992135399.USD","LU1815336760.USD","LU0949170426.SGD","LU0719512351.SGD","IE00BQXX3D17.EUR","LU0823421416.USD","LU1670627923.USD","BK4561","LU0208291251.USD","LU1069344957.HKD","IE00BZ9MQY76.HKD","LU0868494708.USD","LU1280957306.USD","IE00B7KXQ091.USD","LU1074936037.SGD","LU1935042991.SGD","IE00BYV24P56.USD","BK4614","LU0158827948.USD","LU2461242641.AUD","LU0109391861.USD","LU1093756168.USD","BK4588","LU0942090050.USD","BK4566","LU2065170008.USD","NVDA","LU1923622291.USD","IE00BVYPNQ40.USD","IE00BBT3K403.USD","IE0004445015.USD","LU2294711713.HKD","LU0957808578.USD","LU2089284900.SGD","LU0494093205.USD","IE00BDCRKT87.USD","IE00B3M56506.USD","BK4606","SG9999015945.SGD","LU0187121727.USD","LU0127658192.USD","LU0553294199.USD","BK4605","LU2168564065.EUR","LU1206713676.USD","LU1880398554.USD","SGXZ99366536.SGD","LU0889565833.HKD","LU1642822529.SGD","IE0005OL40V9.USD","LU0345769128.USD","IE00B3PB1722.GBP","IE0009G5SDU7.USD"],"gpt_icon":0},{"id":"2606217322","title":"CRISPR Therapeutics AG CFO Prasad Raju Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2606217322","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606217322?lang=en_us&edition=fundamental","pubTime":"2026-01-27 06:35","pubTimestamp":1769466956,"startTime":"0","endTime":"0","summary":"Raju Prasad, Chief Financial Officer of CRISPR Therapeutics AG, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CRISPR Therapeutics AG published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL6vp12X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CRISPR Therapeutics AG CFO Prasad Raju Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","LU1861559042.SGD","CRSP","LU1861558580.USD","BK4588","BK4139","BK4585","BK4556"],"gpt_icon":0},{"id":"2606422635","title":"Beam Therapeutics Chief Legal Officer Christine Bellon Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2606422635","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606422635?lang=en_us&edition=fundamental","pubTime":"2026-01-27 05:05","pubTimestamp":1769461547,"startTime":"0","endTime":"0","summary":"Christine Bellon, Chief Legal Officer of Beam Therapeutics Inc., reported a disposal of common shares of Beam Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beam Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL3fYhK8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Beam Therapeutics Chief Legal Officer Christine Bellon Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4556","BK4535","BK4585","BK4611","BK4505","BK4588","BEAM"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}